1. Thudichum, J.L.W. (1884). The chemical constitution of the brain. Baillère, Tindall, and Cox, London.
  2. Thudichum, J.L.W. (1874). Researches on the chemical constitution of the brain. Report of the Medical Officer of the Privy Council and Local Government Board, 3 :113.
  3. Klenk, E. (1969). On cerebrosides and gangliosides. Prog. Chem. Fats Lipids, 10 : 411-431.
  4. Carter, H.E., Glick, F.J., Norris, W.P., and Phillips, G.E. (1947). J. Biol. Chem., 170 :285.
  5. Shapiro, D., Segal, H., and Flowers, H.M. (1958). J. Am. Chem. Soc., 80 :1194.
  6. IUPAC-IUBMB Joint Commission on Biochemical Nomenclature. (1998). Nomenclature of glycolipids. Carbohydrate Res. 312 :167-175.
  7. Roots, B.I. (1995). Locating lipids in the CNS : an historical perspective. Neurochem. Res., 20 :1261-1268.
  8. Nylhom, P.G., Pasher, I., and Sundell, S. (1990). The effect of hydrogen bonds on the conformation of glycosphingolipids. Methylated and unmethylated cerebroside studied by X-ray single crystal analysis and model calculations. Chem. Phys. Lipids 52 :1-10.
  9. Fantini, J., Maresca, M., Hammache, D., Yahi, N., Delézay, and O. (2000). Glycosphingolipids (GSL) microdomain as attachment platforms for host pathogens and their toxins on intestinal epithelial cells : activation of signal transduction pathways and perturbations of intestinal absorption and secretion. Glycoconj. J. 17 :173-179.
  10. Fantini, J., Cook, D.G., Nathanson, N., Spitalnik, S.L., and Gonzalez-Scarano, F. (1993). Infection of colonic epithelial cell lines by type 1 human immunodeficiency virus is associated with cell surface expression of galactosylceramide, a potential alternative gp120 receptor. Proc. Natl . Acad. Sci. USA 90 :2700-2704.
  11. Karlsson, K.A. (1989). Animal glycosphingolipids as membrane attachment sites for bacteria. Annu. Rev. Biochem. 58 :309-350.
  12. Mahfoud, R., Garmy, N., Maresca, M., Yahi, N., Puigserver, A., and Fantini, J. (2002). Identification of a common sphingolipid-binding domain in Alzheimer, prion and HIV-1 proteins. J. Biol. Chem. 277 :11292-11296.
  13. Tang, W., Seino, K., Ito, M., Konishi, T., Senda , M., Makuuchi, N., Kojima, N., and Mizuochi, T. (2001). Requirement of ceramide for adhesion of Helicobacter pylori to glycosphingolipids. FEBS Lett. 504 :31-35.
  14. Fantini, J., Garmy, N., Mahfoud, R., and Yahi, N. (2002). Lipid rafts : structure, function and role in HIV, Alzheimer’s and prion diseases. Expert Rev. Mol. Med. 2002 :1-22.
  15. Fantini, J. (2003). How sphingolipids bind and shape proteins : molecular basis of lipid-protein interactions in lipid shells, rafts and related biomembrane domains. Cell. Mol. Life Sci. 60 :1027-1032.
  16. Taïeb, N., Yahi, N., and Fantini, J. (2004). Rafts and related glycosphingolipid-enriched microdomains in the intestinal epithelium : bacterial targets linked to nutrient absorption. Adv. Drug Deliv. Rev. 56 :779-794.
  17. Delézay, O., Yahi, N., Tamalet, C., Baghdiguian, S., Boudier, J.A., and Fantini, J. (1997). Direct effect of type 1 human immunodeficiency virus (HIV-1) on intestinal epithelial cell differentiation : relationship to HIV-1 enteropathy. Virology 238 :231-242.
  18. Clayton, F., Kotler, D.P., Kuwada, S.K., Morgan, T., Stepan, C., Kuang, J., Le, J., and Fantini, J. (2001). Gp120-induced Bob/GPR15 activation. A possible cause of human immunoeficiency virus enteropathy. Am. J. Pathol. 159 :1933-1939.
  19. Maresca, M., Mahfoud, R., Garmy, N., Kotler, D.P., Fantini, J., and Clayton, F. (2003). The virotoxin model of HIV-1 enteropathy : involvement of GPR15/Bob and galactosylceramide in the cytopathic effects induced by HIV-1 gp120 in the HT-29-D4 intestinal cell line. J. Biomed. Sci. 10 :156-166.
  20.  Yarema, K.J., and Bertozzi, C.R. (1998). Chemical approaches to glycobiology and emerging carbohydrate-based therapeutic agents. Curr. Opin. Chem. Biol. 2 :49-61.
  21. Weber, K.T., Hammache, D., Fantini, J., and Ganem, B. (2000). Synthesis of glycolipid analogues that disrupt binding of HIV-1 gp120 to galactosylceramide. Biorg. Med. Chem. Lett. 10 :1011-1014.
  22.  Faroux-Corlay, B., Clary, L., Gadras, C., Hammache, D., Greiner, J., Santaella, C., Aubertin, A.M., Vierling, P., and Fantini, J. (2000). Synthesis of single- and double-chain fluorocarbon and hydrocarbon galactosyl amphiphiles and their anti-HIV-1 activity. Carbohydrate Res. 327 :223-260.
  23.  Villard, R., Hammache, D., Delapierre, G., Fotiadu, F., Buono, G., and Fantini, J. (2002). Asymmetric synthesis of water-soluble analogues of galactosylceramide, an HIV-1 Receptor : new tools to study virus-glycolipid interactions. Chem. BioChem. 3 :517-525
  24.   Fantini, J., Hammache, D., Delézay, O., Yahi, N., André-Barrès, C., Rico-Lattes, I., and Lattes, A. (1997). Synthetic soluble analogs of galactosylceramide (GalCer) bind to the V3 domain of HIV-1 gp120 and inhibit HIV-1-induced fusion and entry. J. Biol. Chem. 272 :7245-7252.